No New Trial For Abbott Whistleblower In $219M Stent Row
The whistleblower who in April lost a $219 million suit against Abbott Laboratories over allegedly improperly marketed bile duct stents won't get a new trial, a Texas federal judge ruled on...To view the full article, register now.
Already a subscriber? Click here to view full article